ATCDDD - ATC/DDD Index

Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel: +47 21 07 81 60
E-mail:

Copyright/Disclaimer

New search Hide text from Guidelines

N NERVOUS SYSTEM
N05 PSYCHOLEPTICS

The group is divided into therapeutic subgroups:
N05A - Antipsychotics
N05B - Anxiolytics
N05C - Hypnotics and sedatives

N05A ANTIPSYCHOTICS

This group comprises drugs with antipsychotic actions (i.e. neuroleptics).
Reserpine is classified in C02 - Antihypertensives.
Antipsychotics in combination with antidepressants are classified in N06C - Psycholeptics and psychoanaleptics in combination.
The group is subdivided mainly according to chemical structure.

The DDDs are based on the treatment of psychosis. The substances in this group are sometimes used for other indications in much lower doses.
For depot injections, the DDDs are based on the average recommended doses divided by the dosing interval.

N05AD Butyrophenone derivatives

The DDD for parenteral droperidol is based on treatment of post-operative nausea and vomiting.

ATC code	Name	DDD	U	Adm.R	Note
N05AD01	haloperidol	8	mg	O
		8	mg	P
		3.3	mg	P	depot
N05AD02	trifluperidol	2	mg	O
N05AD03	melperone	0.3	g	O
		0.3	g	P
N05AD04	moperone	20	mg	O
		20	mg	P
N05AD05	pipamperone	0.2	g	O
N05AD06	bromperidol	10	mg	O
		10	mg	P
		3.3	mg	P	depot
N05AD07	benperidol	1.5	mg	O
N05AD08	droperidol	2.5	mg	P
N05AD09	fluanisone
N05AD10	lumateperone

List of abbreviations

Last updated: 2024-01-26